The MVIS® US Listed Pharmaceutical 25 Index (MVPPH) tracks the performance of the 25 largest and most liquid US exchange-listed companies in the pharmaceutical industry. This is a modified market cap-weighted index, and only includes companies that generate at least 50% of their revenue from pharmaceutical related products and services, such as research and development, production, or marketing and sales.
Full MCap of at least 150 mln USD. Three month average-daily-trading volume of at least 1 mln USD at a review and also at the previous two reviews. At least 250,000 shares traded per month over the last six months at a review and also at the previous two reviews.
Pure-Play
Companies have to generate at least 50% revenues from pharmaceuticals.
Diversification
Company weightings are capped at 20%.
Review
Semi-annually with quarterly rebalances.
Index
Last Close
Open
Last
Change
Change (1Y)
Range (1Y)
2,340.31
2,340.31
-
-
29.93%
1,487.10 - 2,637.89
2,953.91
2,953.91
-
-
43.65%
1,768.41 - 3,266.29
3,576.72
3,576.72
-
-
40.84%
2,166.91 - 3,971.25
Timescale Slider
Symbol
IndexName
MVPPH
MVIS® US Listed Pharmaceutical 25 Price Index
MVPPHTRG
MVIS® US Listed Pharmaceutical 25 Total Return Gross Index
MVPPHTR
MVIS® US Listed Pharmaceutical 25 Total Return Net Index
NEWS & RESEARCH
Gain access to all Index Data and receive updates on market developments, index news and corporate announcements.
